SWIXX BioPharma
SWIXX BioPharma is a Healthcare & Life Sciences startup based in Baar, Switzerland, most recent round Series C+, 1 tracked investor.
About SWIXX BioPharma
SWIXX BioPharma is a company founded in 2014 headquartered in Baar, Switzerland. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
SWIXX BioPharma is a specialized distributor of prescription and over-the-counter medicinal products focused on rare diseases in Central and Eastern Europe, serving as a commercialization partner for biotech and pharmaceutical companies in markets where multinational companies do not operate.
Explore SWIXX BioPharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.